Float Short %

13.13

Margin Of Safety %

Put/Call OI Ratio

0.24

EPS Next Q Diff

-0.07

EPS Last/This Y

-0.95

EPS This/Next Y

-0.71

Price

22.19

Target Price

58.54

Analyst Recom

1.27

Performance Q

7.15

Relative Volume

0.75

Beta

1.22

Ticker: CLDX

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-07-04	CLDX	22	0.54	0.33	4913
2025-07-07	CLDX	20.94	0.49	0.01	8411
2025-07-08	CLDX	21.33	0.26	0.00	13704
2025-07-09	CLDX	22.48	0.21	0.00	16157
2025-07-10	CLDX	22.69	0.20	0.38	16840
2025-07-11	CLDX	22.89	0.20	0.03	16976
2025-07-14	CLDX	23.38	0.20	0.00	17585
2025-07-15	CLDX	22.85	0.19	0.07	17762
2025-07-16	CLDX	22.98	0.19	0.30	17757
2025-07-17	CLDX	23.01	0.19	0.49	17908
2025-07-18	CLDX	22.43	0.19	0.04	17940
2025-07-21	CLDX	22.05	0.21	1.46	17105
2025-07-22	CLDX	22.36	0.23	0.79	17660
2025-07-23	CLDX	23.89	0.23	0.37	17697
2025-07-24	CLDX	23.1	0.23	0.52	17860
2025-07-25	CLDX	23.36	0.23	0.08	17857
2025-07-28	CLDX	22.01	0.23	0.47	17947
2025-07-29	CLDX	21.94	0.23	1.20	17950
2025-07-30	CLDX	22.81	0.24	0.14	18071
2025-07-31	CLDX	21.97	0.24	0.06	18087
2025-08-01	CLDX	22.21	0.24	0.00	18096
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-07-04	CLDX	22.00	-55.9	-38.2	-3.40
2025-07-07	CLDX	20.95	-55.9	-17.8	-3.40
2025-07-08	CLDX	21.33	-55.9	-48.7	-3.40
2025-07-09	CLDX	22.46	-55.9	-66.6	-3.40
2025-07-10	CLDX	22.68	-55.9	-45.3	-3.40
2025-07-11	CLDX	22.91	-55.9	-49.9	-3.40
2025-07-14	CLDX	23.34	-55.9	-49.3	-3.40
2025-07-15	CLDX	22.85	-55.9	-30.5	-3.40
2025-07-16	CLDX	22.98	-55.9	-43.3	-3.40
2025-07-17	CLDX	22.97	-55.9	-40.3	-3.40
2025-07-18	CLDX	22.44	-55.9	-30.1	-3.40
2025-07-21	CLDX	22.07	-55.9	-33.3	-3.40
2025-07-22	CLDX	22.37	-55.9	-47.2	-3.40
2025-07-23	CLDX	23.87	-55.9	-72.3	-3.40
2025-07-24	CLDX	23.22	-55.9	-28.3	-3.40
2025-07-25	CLDX	23.35	-55.9	-43.1	-3.40
2025-07-28	CLDX	22.11	-55.9	-16.6	-3.40
2025-07-29	CLDX	21.95	-55.9	-39.3	-3.40
2025-07-30	CLDX	22.81	-55.9	-59.3	-3.40
2025-07-31	CLDX	21.98	-55.9	-23.8	-3.40
2025-08-01	CLDX	22.19	-55.9	-45.2	-3.40
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-07-04	CLDX	0.00	-5.04	12.14
2025-07-07	CLDX	0.00	-5.03	12.14
2025-07-08	CLDX	0.00	-5.03	12.14
2025-07-09	CLDX	0.00	-5.03	12.14
2025-07-10	CLDX	0.00	-5.03	12.14
2025-07-11	CLDX	0.00	-5.03	12.21
2025-07-14	CLDX	0.00	-4.88	12.21
2025-07-15	CLDX	0.00	-4.88	12.21
2025-07-16	CLDX	0.00	-4.88	12.21
2025-07-17	CLDX	0.00	-4.88	12.21
2025-07-18	CLDX	0.00	-4.88	12.21
2025-07-21	CLDX	0.00	-3.41	12.21
2025-07-22	CLDX	0.00	-3.41	12.21
2025-07-23	CLDX	0.00	-3.41	12.21
2025-07-24	CLDX	0.00	-3.41	12.21
2025-07-25	CLDX	0.00	-3.41	13.13
2025-07-28	CLDX	0.00	-3.67	13.13
2025-07-29	CLDX	0.00	-3.67	13.13
2025-07-30	CLDX	0.00	-3.67	13.13
2025-07-31	CLDX	0.00	-3.67	13.13
2025-08-01	CLDX	0.00	-3.67	13.13
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.81

Avg. EPS Est. Current Quarter

-0.84

Avg. EPS Est. Next Quarter

-0.88

Insider Transactions

Institutional Transactions

-3.67

Beta

1.22

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

61.2

Max Drawdown 5-Year %

-73.1

Target Price

58.54

P/E

Forward P/E

PEG

P/S

194.88

P/B

2.1

P/Free Cash Flow

EPS

-2.7

Average EPS Est. Cur. Y

-3.4

EPS Next Y. (Est.)

-4.11

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-2366.07

Relative Volume

0.75

Return on Equity vs Sector %

-49.2

Return on Equity vs Industry %

-30.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

-45.2

Celldex Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 186

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.

stock quote shares CLDX – Celldex Therapeutics, Inc. Stock Price stock today

news today CLDX – Celldex Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CLDX – Celldex Therapeutics, Inc. yahoo finance google finance

stock history CLDX – Celldex Therapeutics, Inc. invest stock market

stock prices CLDX premarket after hours

ticker CLDX fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: CLDX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y